Announcement:
- Please be aware that the registration deadline for the CIHR Foundation Scheme: 2015 2nd Live Pilot funding opportunity is Monday, July 27th. (final reminder)
Funding Opportunities:
- National Sanitarium Association – Innovative Research Program
Awards and Honours:
- UBC Faculty of Medicine – Distinguished Medical Research Lecturer Award (reminder)
Events:
- UBC Centre for Blood Research Summer Seminar Series – Update on paroxysmal nocturnal hemoglobinuria
- Weston Brain Institute – Webinar: Modern Principles of Medicinal Chemistry in Small Molecule Drug Design
- Vancouver Coastal Health Research Institute – Research Methodology & Project Development Workshop Series
FUNDING OPPORTUNITIES:
Deadline: October 1, 2015
The National Sanitarium Association (NSA) invites applications for research grants from investigators in Canadian universities, research hospitals, and research institutes.
NSA grants under the Innovative Research Program are intended to provide well-established investigators with start-up (venture) funding for innovative, emerging, and important new areas of research in the broad field of pulmonary science and medicine. Established fields of research that are supported by traditional funding agencies are not eligible for consideration.
It is expected that during the course of an NSA grant (of up to five years), the investigators will capture grants from traditional funding agencies, so that the project becomes self-sustaining by the end of the NSA funding period.
NSA grants may provide funding of up to $1 million over a period of up to five years. The funds can be used to recruit investigators to an established research group and to provide them with initial salary support; for research equipment and operating expenses; and for the support of graduate students and research fellows.
For further details, please visit the NSA website.
AWARDS AND HONOURS:
Nomination Deadline: August 21, 2015
Every year the Faculty of Medicine recognizes the outstanding lecturers in our medical research fields. Candidates from Basic Sciences or Clinical Sciences are nominated by fellow faculty members on the basis of a distinguished research career, recognition in the medical community and effective contributions to student educational growth over the past year. Nominees are selected by the Faculty of Medicine Research Council. Acceptance of this award is accompanied by a seminar open to all faculty members and students as a part of the Leaders in Medical Discovery Series. The seminar will be accredited for College of Family Physicians of Canada and Royal College of Physicians and Surgeons of Canada credits.
Nominees should be senior Faculty members in the UBC Faculty of Medicine, with distinguished research careers. To nominate someone for this award, please provide the following:
- A supporting letter signed by two nominators, who are both Faculty members in the UBC Faculty of Medicine. Please specify whether the candidate is being nominated for the basic sciences or clinical sciences category.
- An up-to-date copy of the nominee’s curriculum vitae
For further details, please visit our DMRL website.
EVENTS:
UBC Centre for Blood Research Summer Seminar Series – Update on paroxysmal nocturnal hemoglobinuria
Date & Time: July 29, 2015; 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Seminar by:
Dr. Christopher Patriquin
Clinical Scholar in Complement-Mediated Disease, McMaster University
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, non‐malignant clonal disorder of the bone marrow. Hematopoietic cells from PNH clones are exquisitely sensitive to complement‐mediated activation and/or destruction. Clinical presentations include hemolysis, marrow failure, and thrombophilia among others. The development of anticomplement therapeutics has drastically changed the outcome of patients with PNH. Topics to be covered include the pathophysiology of PNH, patient identification, standard treatment, as well as management of special populations. Note will also be made of the Canadian PNH Network as a national resource, and the importance of registry‐based research for ultrarare diseases.
Please contact Dr. Ed Pryzdial (ed.prizdial@blood.ca) to network with the guest speaker.
Date & Time: August 5, 2015; 1-2:30pm EDT
Medicinal chemistry issues are one of the most common sources of issues seen in grant applications to the Weston Brain Institute. In an effort to increase the number of projects we fund and to provide resources to the Canadian neuroscience medical research community, we have partnered with the leading industry and academic researcher Dr. Mike Rafferty to provide an overview of medicinal chemistry and drug design.
If you have applied, or are thinking about applying to us with a project that involves medicinal chemistry, please join us for this free interactive webinar on Wednesday, August 5th, 2015 from 1:00-2:30pm EDT. This webinar is open to any researchers, research staff or students doing research who could be listed as a team member on a grant application to the Weston Brain Institute.
Dr. Rafferty will cover three major topics:
- Challenges inherent in small molecule drug design
- Commonly held misconceptions about small molecule drug discovery
- New tools and techniques for the design of better drug candidates.
Participants will have the opportunity to ask questions, and will have read-only access to the webinar materials after the session.
Register here.
Dr. Mike Rafferty holds a degree in Medicinal Chemistry from the University of Kansas and completed his postdoctoral fellowship at the NIH. Dr. Rafferty retired from Pfizer 2006 as Executive Director of Drug Discovery Technologies after 25 years in small molecule discovery, mostly focused on CNS diseases and six years as Vice President of preclinical development with Decipher Pharmaceuticals, Dr. Rafferty possesses vast knowledge of CNS targeted drug development, and a passion for teaching the applications and modern methods of drug discovery. He has taught modern methods of drug discovery at the graduate level at the University of Kansas and served on several NIH review panels.
If you have any questions about this webinar, please contact Kristina Ognjanovic at kristina.ognjanovic@weston.ca or 416-965-5311.
Date & Time: 2nd Wednesdays of September 2015 to June 2016; 8-10am (subject to change)
Location: Room 10207, Diamond Health Care Centre, 2775 Laurel Street, Vancouver
VCHRI in partnership with C2E2 and the Department of Medicine are pleased to announce a new workshop series. This series is designed for investigators interested in developing additional skills in research methodology, as well as obtaining feedback from both experts and peers on current projects under development. Please refer to the attached flyer for more information.
Each 2-hour session, run once per month, will be focused on investigator-initiated projects and will include a 20-minute review of a specific topic. Topics covered may include:
- Common study designs (case-control, cohort, RCT, adaptive design, feasibility/pilot studies)
- Common biases in observational studies, quasi-experimental studies and randomized trials
- Reducing bias at the design stage (e.g., randomization, choice of control group, outcome ascertainment)
- Sample size, power, precision
- Selection of outcome(s) & questionnaire development
To sign up please here.
For further information, contact: Kerri Abramson at kerri.abramson@vch.ca or Jody Swift at jody.swift@vch.ca
Enrollment will be limited to allow for group discussion, sign up early to avoid disappointment.